Headlines:
Search for Healthcare Articles by

Drug Discovery Services and Clinical Trials


< Previous   Page 3 of 17   Next >
Search returned 168 items.
sort by:   Title | Author | Publication | Date

Washington Report: Vaccines for Everyone

New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access.
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442277

VIDEO-Medical breakthroughs -- what will they look like? VIDEO

http://video.msn.com/v/us/msnbc.htm?f=00&g=0fba1e9a-7886-4b8e-8092-c407700beee9

New Critical Path Report Highlights Research Needed to Foster Generic Drug Development

The report is part of FDA's Critical Path Initiative, established in 2004 to discern what challenges exist in moving a promising drug, biologic or device along the critical path from discovery, or proof of concept, to a marketable product
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01626.html

Deals: Roche Goes Shopping

BioVeris purchase locks in a key diagnostic technology. PLUS: Eisai buys Morphotek, IMS gets more outcomes-research muscle, and other top deals.
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423197

Ukraine Emerges as a Viable Location for Global Studies

Trials are on the rise in the country, where recruitment rates are high but custom procedures can pose a problem.
http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4

Investigative Sites Unlock the Door to Success in India

The clinical development sector in India engaged in global clinical trials for product registration with international regulatory bodies is fast approaching an inflection point.
http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4

CRO Shifts in the Outsourcing Market

The CRO market is going through major and unanticipated structural changes
http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4

Opinion: Are Price Controls the New Black?

...the legislation might just pass—and spell failure for the future of innovative drug development.
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423214

Critical Mass for Critical Path?

...the rewards of collaboration now look greater than the risks....
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423202

Washington Report: Pathways for Proteins

Innovators want exclusivity and clinical studies for follow-on biologics,
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423212
< Previous   Page 3 of 17   Next >
Search returned 168 items.
Sponsored Links
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
A respected source of IT information
in the healthcare market
www.biotechmedia.com